Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 20/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 19/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 19/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 19/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 18/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 18/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 18/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 18/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 18/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 18/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 18/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18371376 | 1.00 | HDAC6 (0.42) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL7958854 | 0.87 | HDAC6 (0.40) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16302045 | 0.85 | HDAC1 (0.49) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL8011347 | 0.85 | HDAC1 (0.49) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16302069 | 0.83 | HDAC6 (0.47) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16581065 | 0.83 | HDAC6 (0.47) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16302008 | 0.83 | HDAC1 (0.53) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16302037 | 0.82 | HDAC6 (0.55) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL7997961 | 0.82 | HDAC6 (0.55) | HDAC6HDAC3HDAC1HDAC2HDAC4 | |
| SCHEMBL16302041 | 0.82 | ALOX15 (0.43) | HDAC6HDAC3HDAC1HDAC2HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110288070-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING INHIBITORS OF HISTONE DEACETYLASE | FMR LLC | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288070-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC5, HDAC2 | HDAC6 9/4885HDAC3 14/4885HDAC1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.